A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer
Clinical trial NCT00642018 · COMPLETED
Trial details
- NCT number
- NCT00642018
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2011-08-01
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.